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Infiltration of the kidney by aj3 and y! T cells: Effect on progression in
IgA nephropathy. We have studied renal biopsies from three groups of
patients to determine if a T cells or y& T cells are present, and whether
their presence is correlated with disease progression in IgA nephropathy
(IgAN). Group one comprised thin basement membrane disease biopsies
(non-immunological control, N = 7); group two were patients with IgAN
and stable renal function one year following biopsy (stable, N = 7); and
group three were IgAN patients with rapidly declining renal function after
one year (progressive, N = 7). Immunohistochemical staining using
monoclonal antibodies (CD3, TcRI3, TcRb) and molecular studies utiliz-
ing polymerase chain reaction amplification of cDNA transcribed from
biopsy RNA, with primers specific for either the a TcR or yb TcR, were
undertaken. On immunohistochemistry a significant increase in CD3 +
cells in progressive biopsies was seen (vs. control P = 0.002, vs. stable P =
0.002). The progressive biopsies infiltrate consisted of both af3 TcR (vs.
control P = 0.001, vs. stable P = 0.003) and yb TcR cells (vs. control P =
0.01). The RNA study demonstrated an increase in TcR Ca transcription
in the progressive (vs. control P = 0.003) biopsies. Increased TcR C
transcription was seen in the progressive group (vs. control P = 0.01, vs.
stable P = 0.02). We confirm that the presence of lymphocytes in IgAN
biopsies predicts progressive disease. While af3 T cells are found in both
stable and progressive disease, the presence of yb T cells is only associated
with progressive IgAN.
Primary IgA nephropathy (IgAN), characterized by the accu-
mulation of deposits of IgA in the glomerular mesangium, is the
commonest form of glomerulonephritis in the developed world
[1]. Since Berger and Hinglais' original description [2] the immu-
nological mechanisms implicated in the pathogenesis of IgAN
have been extensively investigated, yet remain poorly understood
[3, 4]. Although the disease is defined by humoral factors, recent
evidence suggests that cell mediated immunity plays a role in the
progression to renal failure [5]. T lymphocyte infiltration into the
renal interstitium is more marked in those patients who have
impaired renal function at the time of biopsy than in those with
normal function [6, 7] and predicts the group of patients whose
renal function will deteriorate [7].
Characterization of infiltrating T cells has yielded conflicting
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results. Some groups suggest a predominance of CD8 bearing
lymphocytes [7] while others have demonstrated CD4 cells as the
dominant type [6, 8]. T cells may also be categorized as bearing
the af3 T cell receptor (af3 TcR) or the less common and only
recently described 'y8 receptor (y TcR) [9]. Both have similar
effector functions, including cytotoxicity and helper/inducer func-
tion, but the 'y T cells seldom require MHC molecules for
antigen recognition [10]. No study is presently available which
documents the types of TcR found in IgAN biopsies, nor has the
presence or absence of either receptor been correlated with the
severity or progression of disease.
We have used immunohistochemical staining and RNA analysis
to study renal biopsies from patients with stable IgAN, progressive
IgAN and non-immunological renal disease to determine if af3 T
cells or yb T cells are present and if their presence is correlated
with disease progression. The data obtained indicate that af3 T
cells and y8 T cells are involved in the progression of IgAN to
renal failure. y T cells are only found in progressive IgAN.
Methods
Patient selection
Thirty-four renal biopsies of adult patients from the Royal
Adelaide Hospital archival collection were selected for analysis.
Twenty-three showed histological evidence of IgAN as defined by
the presence of dominant or co-dominant glomerular mesangial
staining for IgA [11]. Eleven had normal light microscopy and
immunofluorescence, but upon electron microscopy showed thin
basement disease. The group with IgAN were divided into those
with progressive disease or those with a stable clinical course. All
biopsies were taken with a 14 gauge Tm-Cut (Baxter) biopsy
needle, embedded in OCT (Miles Laboratories), and stored at
—80°C for a period up to 11 years (mean 5 years). Three groups
of biopsies were therefore analyzed.
Group 1: IgA nephropathy/no progression. Twelve biopsies were
taken from patients with IgAN who at least 12 months after biopsy
had a normal glomerular filtration rate (GFR) either measured or
calculated from serum creatinine.
Group 2: IgA nephropathy/progression. Eleven biopsies were
taken from patients with IgAN who at least 12 months after biopsy
showed at least a 50% decline in their GFR (either as measured
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or as evidenced by an increase in serum creatinine from the
normal range to a figure exceeding 200 molIliter).
Group 3: Non-immunological renal disease (thin basement mem-
brane disease). Eleven biopsies were from patients with hematuria
who subsequently proved to have thin basement membrane
disease, and whose renal function has remained normal over a 12
month period. This group was chosen as a control group because
of the availability of non-inflammatory renal disease characterized
by hematuria.
Controls
Control tissue was obtained from five patients undergoing
nephrectomy. Four had required removal of a Wilm's tumor.
Renal tissue was obtained from the unaffected pole which showed
no histological evidence of tumor infiltrating lymphocytes. One
control nephrectomy specimen was from a patient with an in-
fected kidney showing extensive mononuclear cell infiltrate. Blood
was obtained from 12 healthy volunteers and pooled to form a
positive control for TcR expression.
Appropriate conditions for immunohistochemistry were estab-
lished on frozen section of human tonsil removed for clinical
indications. The characteristic regional distribution of a13 and
T cells were observed [12].
Ethics approval
Ethics approval was granted by the Ethics Committee at The
Children's Hospital, Camperdown, Australia.
RNA extraction, reverse transcription and amplification
Peripheral blood mononuclear cells (PBMC) were separated on
a Lymphoprep density gradient (Nycomed). Renal tissue was cut
from OCT using a scalpel blade while the temperature was
maintained at —80°C. Cell lysis of renal tissue was performed
using a tissue grinder (Wheaton) under RNAse free conditions.
RNA from each homogenate and pelleted PBMC was then
extracted by a single-step guanidinium thiocyanate/phenol chlo-
roform procedure using the method of Chomczynski and Sacchi
[13]. RNA yield was checked by spectrophotometry and con-
firmed by agarose gel electrophoresis after staining with ethidium
bromide and comparison with known standards. RNA samples
were discarded if clear ribosomal bands were not visible in the
agarose gel or if less than 0.5 g was extracted.
Maloney murine LV reverse transcriptase (BRL) was used to
convert mRNA to cDNA using random hexamer primers and
heating to 37°C for 60 minutes.
Primers and polymerase chain reaction
Oligonucleotide primers for J3-actin and the TcR delta constant
region (TcR C) genes were designed using Pcrprim software [14]
(Table 1). Primers for the TcR alpha constant region (TcR Ca)
were those previously described by Choi et al [15]. PCR condi-
tions for biopsy tissue and PBMC were identical, with cDNA
amplified at 95°C, 60°C and 72°C for one minute each cycle after
addition of dNTPs, Taq polymerase and PCR buffer (Boehringer
Mannheim). 13-actin amplification was for 27 PCR cycles while the
TCR constant region amplifications were for 30 cycles. PCR
products were electrophoresed in a 2% agarose gel and the length
of the product was assessed by comparison with 100 base pair
ladder after staining with ethidium bromide and viewing under
short-wave ultraviolet light.
Table 1. T cell receptor constant regions and /3-actin oligonucleotides
Primer 5' —*3'
TCR C8 Forward 5'-ATGTCGCTFGTCTGGTGAAG-3'
TCR C Reverse 5'-GTCAGAAGCCAAGGAGATGC-3'
TCR C Probe 5'-GCCATAGTFCATACCGAGAAGG-3'
TCR Ca Reverse 5'-ATCATAAAITCGGGTAGGATCC-3'
TCR Ca Forward 5'-GAACCCTGACCCTGCCGTGTACC-3'
TCR Ca Probe 5'-GGTGAATAGGCAGACAGACTTGTC
ACTGGA-3'
13-actin Forward 5 '-AACACAGTGCTGTCTGUC-3'
/3-actin Reverse 5'-CAACTAAGTCATAGTCCGCC-
/3-actin Probe 5'-TCGTCATACTCCTGC11TGC-3'
Dot blotting and hybridization. The PCR products were trans-
ferred to a Zetaprobe membrane (Biorad) using a Biorad dot blot
apparatus. Specific oligonucleotide probes directed at segments
internal to the amplified TcR Ca, TcR Cfl and /3-actin (Table 1)
were end labeled with y32P-ATP. Hybridization was performed
overnight in a sodium phosphate-EDTA-7% SDS buffer and
following serial washings the membrane was placed on an x-ray
film and the autoradiograph exposed for one to two hours. Dot
blot hybridization was employed after Southern blot analysis had
confirmed the size of the PCR product. Two dimensional densi-
tometry was undertaken on the autoradiograph using a comput-
erised densitometer (Molecular Dynamics) and ImageQuant V
3.0 software.
Standardization of PCR quantitation. Serial dilutions of a known
concentration of pooled PBMC cDNA were subjected to PCR
amplification for /3-actin, TcR Ca and TcR C. Standard curves
were constructed in triplicate over a range of concentrations to
establish amplification plateau. Semi-quantitative PCR was shown
to be a reproducible measure of TcR constant region and f3-actin
expression within the limits of the standard curves. Standardized
dilutions of all experimental samples were chosen to remain
within these limits. All samples were measured at least twice and
the mean densitometry score calculated. Variation between du-
plicates was less than 5%.
Immunoperoxidase staining
Frozen sections were fixed in acetone overnight at —20°C and
dried for one hour at room temperature. Primary monoclonal
antibodies anti-TcR f3F1 (T Cell Diagnostics), anti-TcR 6F1 (T
Cell Diagnostics) and anti-CD3 (Dako) were diluted to 1:50 using
a diluent buffer and applied for 30 minutes at room temperature.
Second antibody, goat anti-mouse Ig-Biotin (Dako), diluted 1:300
with diluent buffer was added for 30 minutes at room temperature
followed by avidin-biotin-peroxidase complex (Dako) for 20 min-
utes at room temperature and DAB (Sigma) substrate 0.6 mg/ml
for one minute. Counterstain was with Mayer's hemotoxylin and
results were analyzed by two independent observers with a simple
four point scoring scale: 0 = no cells seen; 1 = < 5 cells per high
power field (hpf); 2 = 5 to 100 cellslhpf; 3 = focal infiltrate (focal
clusters of cells in a periglomerular or perivascular distribution) >
100 cells/hpf; 4 = diffuse infiltrate> 100 cells/hpf.
Statistical and data analysis
The PCR studies were standardized to allow for variability in
the amount of biopsy tissue, RNA recovery and efficiency of
reverse transcription. All results were expressed as the ratio of
TCR densitometry score to /3-actin densitometry score. TcR:/3-
actin ratios for each clinical group were analyzed using the
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Fig. 1. Comparison of immunohistochemical staining of lymphocyte subsets
using monoclonal antibodies in 3 groups of renal biopsies. Abbreviations are:
C, control (thin basement membrane disease); S, stable IgAN; P, progres-
sive IgAN. Results are plotted as mean SEM. **P < 0.01.
Shapiro Wilk Test to test for sample distribution and selection of
appropriate analyses (parametric or non-parametric). In all cases
the data was normally distributed. One-way analysis of variance
(ANOVA) was performed on the three groups. P < 0.05 was
accepted as statistically significant. Fisher's exact test was applied
to the three groups to determine whether significant differences
between pairs of groups were present. Immunohistology scores in
each group were analysed with the same statistical approach.
Pearson's correlation coefficient was used to determine the
relationship between the number of years the biopsies had been
stored and the mRNA yield.
Results
RNA extraction
Suitable RNA for analysis was obtained from 21 of the 34
biopsies. There was no correlation between the length of storage
and the yield and quality of RNA (r = 0.278). Seven biopsies
proved suitable for analysis from each of the three groups:
non-immunological, stable IgAN and progressive IgAN.
Blood and tissue controls
Pooled blood from 12 healthy volunteers yielded readily detect-
able expression of TcR Ca, TcR C8 and 13-actin for the construc-
tion of standard curves. A logistic regression analysis of these
sigmoidal curves showed that for Ca r2 0.83; C8 r2 = 0.90;
f3-actin r2 = 0.92. Samples from the unaffected pole of the kidneys
removed for Wilm's tumor which were histologically clear of both
tumor and tumor infiltrating lymphocytes demonstrated no signal
for TcR Ca or TcR C& Strong signals for TcR Ca and TcR C5
were seen in the sample from the kidney with suppurative
pyelonephritis.
Analysis of groups (immunohistochemistty)
Lymphocytes were not detected in the unaffected pole of
Wilm's tumor nephrectomy specimens used as negative control
samples. There was minimal lymphocyte infiltration in the thin
basement membrane disease biopsies. The IgAN stable group
showed scattered cells only. The IgAN progressive group had an
extensive CD3 infiltrate (Fig. 1). Statistical analysis of the T cells
stained by an anti-CD3 monoclonal antibody using one-way
Statistical method Group P value
Immunohistology
Anti-CD3 antibody
ANOVA 0.0016
Fisher's LSD C vs. S
C vs. P
S vs. P
NS
0.002
0.002
Anti-TcR j3 antibody
ANOVA 0.0003
Fisher's LSD C vs. S
C vs. P
S vs. P
NS
0.000 1
0.003
Anti-TcR 8 antibody
ANOVA 0.016
Fisher's LSD C vs. S
C vs. P
Svs.P
NS
0.008
NS
Molecular analysis
TcR ajl
ANOVA 0.011
Fisher's LSD C vs. S
C vs. P
Svs.P
NS
0.0003
NS
TcR yb
ANOVA 0.021
Fisher's LSD C vs. S
C vs. P
S vs. P
NS
0.009
0.02
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Fig. 2. Comparison of semiquantitative PCR analysis of the expression of
TCR constant region genes in 3 groups of renal biopsies after correction for
the mass of tissue per biopsy by espression as a ratio to j3-actin signal.
Abbreviations are: C, control (thin basement membrane disease); S, stable
IgAN; P, progressive IgAN. Results plotted as mean SEM. < 0.01;
*p < 0.05.
ANOVA demonstrated a significant difference (P = 0.0016)
between the three groups. Using Fisher's least significant differ-
ence test, a significant difference between IgAN progressive and
IgAN stable (P = 0.002) and between IgAN progressive and the
non-immunological group (P = 0.002) was present. No statistical
difference between the non-immunological group and stable
IgAN could be demonstrated (Table 2).
Table 2. Statistical results of af3 and yb T cells infiltrating renal
biopsies using immunohistology and molecular analysesAnti-CD3 Anti-TcR Anti-TcR
** ** **
I I
** **
f
41
Abbreviations are: ANOVA, one-way analysis of variance; C, non-
immunological renal disease; S, stable IgA nephropathy; P, progressive
IgA nephropathy; Fisher's LSD, Fisher's least significant difference test.
TcR Ca
**
a)
E
TcR Co
**
I * I
I
0
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Fig. 4. Archival renal biopsies from patients with thin basement disease (A, B, C) and progressive IgA nephropathy (D, E, F). Sections stained with
monoclonal antibodies to CD3 (A, D), TcR /3S1 (B, E) and TcR (C, F) and a polyclonal peroxidase conjugated anti-mouse IgG second antibody.
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Analysis of a/3 T cells infiltrating renal biopsies using a mono-
clonal antibody directed against the TcR /3 chain revealed a
pattern similar to the CD3 results. Extensive af3 T cell infiltration
was present in the progressive IgAN biopsies with only a minimal
number of cells detected in the stable IgAN group and non-
immunological biopsies (Fig. 1). Statistical analysis of the T cells
stained by an anti-TcR /3 monoclonal antibody using one way
ANOVA demonstrated a significant difference (P = 0.0003)
.
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Fig. 3. PCR standard curves for j3-actin, TCR Ccc, and TCR C
comparing in triplicate serial dilutions of cDNA (log scale) to densitometiy
signal after amplification. Results are plotted as mean SEM.
between the three groups. Using Fisher's least significant differ-
ence test, a significant difference between IgAN progressive and
IgAN stable (P = 0.003) and between IgAN progressive and the
non-immunological group (P = 0.0001)was present. No statistical
difference between the non-immunological group and stable
IgAN could be demonstrated (Table 2).
Analysis of y T cells infiltrating renal biopsies using a mono-
clonal antibody directed against TCR y chain revealed only rare
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Fig. 4. Continued.
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cells in the non-immunological group, and very few cells in the
stable IgAN group. Frequent y6 T cells were seen in the progres-
sive IgAN group (Fig. 1). Statistical analysis of the T cells stained
by an anti-TcR monoclonal antibody using one way ANOVA
demonstrated a significant difference (P = 0.016) between the
three groups. Using Fisher's least significant difference test a
significant difference between IgAN progressive and the non-
immunological group (P = 0.008) was present. No statistical
difference between the non-immunological group and stable
IgAN nor the stable IgAN vs. progressive IgAN groups could be
demonstrated (Table 2).
The overall pattern seen on immunohistochemistry showed
significant T cell infiltration in the IgAN progressive group, in
which both a13 and y& T cells were seen. af3 T cells were also seen
in the IgAN stable biopsies but to a lesser extent, while y5 T cells
were essentially restricted to the IgAN progressive group.
Analysis of groups by RNA
The TcR Ca and TcR C results were corrected for the amount
of tissue available in each biopsy by expressing as a ratio to the
f3-actin signal from each biopsy (Fig. 2).
Signal for both TcR constant regions could be detected in all
groups. TcR Ca expression was low for the non-immunological
group, modest in the stable IgAN group and strong in the
progressive IgAN group. Statistical analysis of the TcR Ca signals
using one way ANOVA demonstrated a significant difference
(P = 0.011) between the three groups. Using Fisher's least
significant difference test a significant difference between IgAN
progressive and non-immunological group (P 0.0003) was
present. No statistical difference between the stable IgAN and
non-immunological groups and the IgAN progressive and stable
IgAN groups could be demonstrated. TcR Ca expression could
not be detected in renal biopsy tissue taken from the unaffected
pole of Wilm's tumor nephrectomy specimens.
TcR C expression was low in the non-immunological group
and in the stable IgAN group, but stronger for the progressive
IgAN group (Fig. 2). Statistical analysis of the TcR C signals
using one way ANOVA demonstrated a significant difference (P
= 0.021) between the three groups. Using Fisher's least significant
difference test, a significant difference between IgAN progressive
and the non-immunological group (P = 0.009) was present. No
statistical difference between the IgAN stable and the IgAN
progressive groups could be demonstrated, nor between IgAN
stable or the non-immunological groups. TcR C expression could
not be detected in renal biopsy tissue taken from the unaffected
pole of Wilm's tumor nephrectomy specimens.
The overall pattern of TcR constant region gene transcription
was that afi TcR was detected in both stable and progressive
IgAN but significantly elevated y TcR signal was restricted to the
progressive IgAN group.
Analysis of groups by age distribution
There was no significant difference between the ages of the
patients in the three groups: thin basement membrane disease 38
4 years (mean SEM), stable IgAN 46 3 years and
progressive IgAN 46 5 years.
Discussion
IgA nephropathy is characterized by a stereotypic pattern of
glomerular IgA deposition. The clinical course is far from fixed,
however. The outcome ranges from complete resolution of symp-
toms to a rapid progression into renal failure. The clinical markers
in IgAN which foreshadow a poor prognosis include heavy
proteinuria, hypertension and reduced renal function at the time
of biopsy [16]. The histological findings of a severe glomerular
lesion [11] and/or interstitial sclerosis [16] are also associated with
subsequent progression to renal impairment. Our study using both
an immunohistochemical approach and analysis of tissue mRNA
demonstrated that the infiltration of T cells into the renal
interstitium of patients with IgAN similiarily correlates with an
unfavorable outcome.
While the interstitial patterns of tubular atrophy, interstitial
fibrosis and inflammation have been thought to be processes
secondary to severe glomerular disease, there is little evidence to
support or refute this assertion. Recently two groups who ana-
lyzed the relationship between lymphocytic infiltration and clinical
outcome found firstly that T cells are more abundant in the
interstitium in those patients who have impaired renal function at
the time of biopsy [6, 7], and secondly that T cell infiltration
predicts the group of patients whose renal function will deterio-
rate. However, these groups differed in their characterization of
CD4 and CD8 markers carried by the majority of infiltrating cells,
showing that either helper/inducer or cytotoxic T cells predomi-
nate in the interstitium of IgAN biopsies. These findings, togeth-
er with ours, suggest that a cell-mediated immune response is
occurring in the interstitium. It also may explain why patients with
similar glomerular lesions but different degrees of tubulointersti-
tial inflammation have vastly different clinical outcomes.
We have demonstrated that the af3 T cell infiltration into renal
tissue of all three patient groups closely followed that of the total
lymphocyte population. af3 T cells were found in the interstitium
of the stable and progressive IgAN kidneys, but significantly more
were present in the progressive group than in the stable and
non-immunological groups. The predominance of a T cells in
this study is not unexpected as 90 to 95% of peripheral blood T
cells bear the a/3 TcR. T cell infiltration may be initiated either by
a specific local antigen or as part of a generalized recruitment of
inflammatory cells to an area of inflammation. Our study was not
designed to distinguish which of these mechanisms was operating.
A study to examine the V region subfamily repertoire of these
infiltrating cells could address this question. If a restricted reper-
toire of af3 TcR or y TcR was present one could hypothesize that
a clonal response to a specific antigen in the renal interstitium was
acting as a trigger for infiltration, whereas if a polyclonal reper-
toire was detected, then simple recruitment of T cells to an
inflammatory focus would be implied.
Both the immunohistochemical and RNA analyses showed that
T cells are only seen in the kidneys of patients who progress to
renal failure. Our understanding of the antigen specificity and
physiological function of T cells is incomplete. They are more
commonly found at mucosal epithelial surfaces than in blood [17].
Their ability to proliferate in response to antigen is not restricted
by the requirement for MHC presentation [10]. The discovery that
microbial antigens, including mycobacterial antigens, can induce
T cell proliferation has been a major step forward in under-
standing the role of y T cells in inflammatory processes [18, 19].
The mycobacterial antigen Hsp65, a strong stimulator of T cells
[20] is a member of the ubiquitous heat-shock protein family of
intracellular glycoproteins (Hsp). Although originally named be-
cause of their up-regulation in cells which have undergone
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physical stress (such as changes in temperature) [21], they have
also been found to be constitutively expressed and to be involved
in cytoplasmic housekeeping functions [22]. Most recently Hsp
have also been recognized as an antigen common to many
pathogenic bacteria [23]. Hsp expressed on the cell surface can
function as a target molecule for y8 T cells [22] and can cause the
proliferation of particular oligoclonal subsets of y T cells [19].
We speculate that y T cells proliferating in response to
microbial antigens at a mucosal surface may circulate in the blood,
invade the kidney and recognize Hsp expressed on the surface of
stressed renal parenchymal cells, in a classical "molecular mimic-
ry" manner. This conjecture is supported indirectly by the obser-
vation that IgAN patients immunized with tetanus toxoid mount
exaggerated 'y T cell responses in peripheral blood in addition to
exaggerated production of IgA anti-tetanus toxoid antibodies [241,
and by the ability of y T cells to home to mucosal epithelia [17].
Similar mechanisms appear to play a part in the pathogenesis of
other autoimmune diseases in which increased antibodies against
Hsps have been reported, including type I diabetes [25], autoim-
mune thyroid disease [26] and systemic lupus erythematosis [27].
Hsp65-responsive y T cells cross reactive with a synovial antigen
can be cloned from joint aspirates of patients with rheumatoid
arthritis [28, 29], and the 'yö T cells which are found in rheumatic
joints have been shown to be oligoclonal [30]. The initiation of this
process of mucosal stimulus, y T cell proliferation and renal
insult may be the additional factor which leads to renal impair-
ment in a subset of IgAN patients. A study of the clonality of these
infiltrating cells could provide further support for the hypothesis.
In conclusion, we have demonstrated by two techniques that T
cell infiltration of the renal interstitium of patients with IgAN is
associated with a poor prognosis. T cells bearing the a/3TCR are
the predominant cell type in both stable and progressive disease,
but are much more numerous in the latter. T cells bearing the y
TCR are found exclusively in the kidneys of patients who progress
to renal failure.
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